Maxcyte annual gross margin
2019
2020
2021
2022
2023
2024
2025
Maxcyte Gross Margin Growth & History (MXCT)
Maxcyte's gross margin was 127.90% for fiscal 2025.
View full Maxcyte company overviewMaxcyte annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 127.90% | −14.02 pp |
| 2024 | 2024-12-31 | 141.92% | −45.53 pp |
| 2023 | 2023-12-31 | 187.44% | +51.22 pp |
| 2022 | 2022-12-31 | 136.23% | −3.99 pp |
| 2021 | 2021-12-31 | 140.22% | −11.24 pp |
| 2020 | 2020-12-31 | 151.45% | +7.22 pp |
| 2019 | 2019-12-31 | 144.23% | — |
Maxcyte quarterly gross margin
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 113.37% | −6.62 pp |
| Q1 2026 | 2026-03-31 | 179.56% | +24.71 pp |
| Q4 2025 | 2025-12-31 | 118.86% | +12.97 pp |
| Q3 2025 | 2025-09-30 | 113.69% | +2.57 pp |
| Q2 2025 | 2025-06-30 | 119.99% | −60.09 pp |
| Q1 2025 | 2025-03-31 | 154.85% | −23.14 pp |
| Q4 2024 | 2024-12-31 | 105.90% | −190.46 pp |
| Q3 2024 | 2024-09-30 | 111.12% | −62.39 pp |
| Q2 2024 | 2024-06-30 | 180.08% | +43.71 pp |
| Q1 2024 | 2024-03-31 | 177.99% | +25.37 pp |
| Q4 2023 | 2023-12-31 | 296.36% | +156.13 pp |
| Q3 2023 | 2023-09-30 | 173.51% | +43.85 pp |
| Q2 2023 | 2023-06-30 | 136.37% | +14.82 pp |
| Q1 2023 | 2023-03-31 | 152.62% | −0.86 pp |
| Q4 2022 | 2022-12-31 | 140.24% | +21.31 pp |
| Q3 2022 | 2022-09-30 | 129.66% | −34.29 pp |
| Q2 2022 | 2022-06-30 | 121.56% | −28.35 pp |
| Q1 2022 | 2022-03-31 | 153.48% | +16.61 pp |
| Q4 2021 | 2021-12-31 | 118.93% | −10.17 pp |
| Q3 2021 | 2021-09-30 | 163.95% | −37.41 pp |
| Q2 2021 | 2021-06-30 | 149.91% | — |
| Q1 2021 | 2021-03-31 | 136.87% | — |
| Q3 2020 | 2020-09-30 | 129.10% | — |
| Q2 2020 | 2020-06-30 | 201.35% | — |
Maxcyte gross margin trends
Over the last five reported fiscal years, Maxcyte's gross margin decreased from 151.45% to 127.90%, a change of −23.55 percentage points. The latest reported quarter, Q2 2026, shows 113.37%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maxcyte filings at SEC.gov ↗